Table 1.
Definition of MetS
| Definition | Central Obesity | Insulin Resistance | Abnormality in Lipid Metabolism | Hypertension | |
|---|---|---|---|---|---|
| World Health Organization152 (Additional criteria: microalbuminuria) |
Waist/hip ratio: Men > 0.90 Women > 0.85 BMI > 30 kg/m2 |
FBG ≥ 110 mg/dL (6.1 mmol/L) | TG ≥ 150 mg/dL (1.7 mmol/L) | HDL-c Men < 35 mg/dL (0.9 mmol/L) Women < 39 mg/dL (1.0 mmol/L) |
Systolic ≥ 160 and/or diastolic ≥ 90 mm Hg |
| NCEP-ATP III153 | Waist circumference: Men > 120 cm Women > 88 cm |
FBG ≥ 110 mg/dL (6.1 mmol/L) | TG ≥ 150 mg/dL (1.7 mmol/L) | HDL-c Men < 40 mg/dL (1.0 mmol/L) Women < 50 mg/dL (1.3 mmol/L) |
Systolic≥ 130 and/or diastolic ≥ 85 mm Hg |
| International Diabetes Federation154 | Waist circumference: Follow population specific cut-off values |
FBG ≥ 100 mg/dL (5.6 mmol/L) | TG ≥ 150 mg/dL (1.7 mmol/L) or taking drugs to lower TG |
HDL-c Men < 40 mg/dL (1.0 mmol/L) Women < 50 mg/dL (1.3 mmol/L) or taking drugs to improve HDL level |
Systolic≥ 130 and/or diastolic ≥ 85 mm Hg or taking drugs to lower blood pressure |
| AHA/NHLBI33 | Waist circumference: Men > 102 cm Women > 88 cm |
FBG ≥ 100 mg/dL (5.6 mmol/L) or taking drugs to lower FBG |
TG ≥ 150 mg/dL (1.7 mmol/L) or taking drugs to lower TG |
HDL-c Men < 40 mg/dL (1.0 mmol/L) Women < 50 mg/dL (1.3 mmol/L) or taking drugs to improve HDL level |
Systolic≥ 130 and/or diastolic ≥ 85 mm Hg or taking drugs to lower blood pressure |
| Joint Interim Statement30 | Waist circumference: Follow population specific cut-off values |
FBG ≥ 110 mg/dL (6.1 mmol/L) or taking drugs to lower FBG |
TG ≥ 150 mg/dL (1.7 mmol/L) or taking drugs to lower TG |
HDL-c Men < 40 mg/dL (1.0 mmol/L) Women < 50 mg/dL (1.3 mmol/L) or taking drugs to improve HDL level |
Systolic≥ 130 and/or diastolic ≥ 85 mm Hg or taking drugs to lower blood pressure |
Abbreviations: AHA/NHLBI, The American Heart Association and the National Heart, Lung, and Blood Institute; FBG, fasting blood glucose; HDL-c, high-density lipoprotein cholesterol; NCEP-ATP III, National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults III; TG, triglycerides.